“…According to recently published data from the US Department of Health and Human Services, among all hemodialysis patients in 2020 62.60% of patients used an arteriovenous fi stula, 20.70% used a temporary or permanent central venous catheter, and 16.70% of patients -used an arteriovenous prosthesis [2].Due to the peculiarities of hemodynamics and the hemodialysis procedure, the most common vascular access lesions are thrombosis, stenoses, aneurysms, pseudoaneurysms, and infectious lesions. As a result of processing the data of more than 77 thousand sick residents of the USA with the terminal stage of CKD, who are on HD, among patients with arteriovenous fi stula during the 3 years of its use, 69.11% required surgical intervention in order to restore the functioning of vascular access, on the other hand, the need for surgical correction of arteriovenous prostheses for the corresponding period was greater and amounted to 87.21% [3].In Ukraine, as of February 1, 2023, there were treated 11,181 people with the help of the RRT method, of which 8,717 were treated by the HD method, that is, they needed permanent vascular access [4]. In the world, and in our country in particular, there is a tendency to increase the prevalence of CKD, therefore, the search for effective methods of preventing the development of hemodynamic lesions of arteriovenous accesses and increasing the duration of their use for RRT remains relevant.Therefore, the aim of this study was a retrospective analysis of hemodynamic disorders and peculiarities of the use of arteriovenous prostheses as permanent vascular access in patients undergoing hemodialysis therapy.…”